The Oncology Institute Inc
(TOI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 98,578 | 94,666 | 85,788 | 82,035 | 80,224 |
| Cost of Goods | 85,552 | 82,697 | 71,409 | 66,057 | 65,107 |
| Gross Profit | 13,026 | 11,969 | 14,379 | 15,978 | 15,117 |
| Operating Expenses | 29,942 | 30,638 | 30,076 | 29,960 | 30,162 |
| Operating Income | -16,364 | -17,972 | -15,288 | -13,925 | -14,938 |
| Interest Expense | 2,118 | 1,985 | 1,941 | 1,755 | 1,638 |
| Other Income | 3,003 | 68 | -1,839 | -1,604 | -222 |
| Pre-tax Income | -15,479 | -19,889 | -19,068 | -17,284 | -16,798 |
| Income Tax | N/A | N/A | -314 | 135 | 99 |
| Net Income Continuous | -15,479 | -19,889 | -18,754 | -17,419 | -16,897 |
| Net Income | $-15,479 | $-19,889 | $-18,754 | $-17,419 | $-16,897 |
| EPS Basic Total Ops | -0.17 | -0.22 | -0.21 | -0.19 | -0.19 |
| EPS Basic Continuous Ops | -0.21 | -0.27 | -0.25 | -0.24 | -0.23 |
| EPS Diluted Total Ops | -0.17 | -0.22 | -0.21 | -0.19 | -0.19 |
| EPS Diluted Continuous Ops | -0.21 | -0.27 | -0.25 | -0.24 | -0.23 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.22 | -0.21 | N/A | N/A |
| EBITDA(a) | $-13,408 | $-15,248 | $-14,058 | $-9,784 | $-12,734 |